Luminex logo

LMNX - Luminex News Story

$36.58 -0.0  -0.1%

Last Trade - 18/05/21

Sector
Healthcare
Size
Mid Cap
Market Cap £1.23bn
Enterprise Value £1.21bn
Revenue £309.7m
Position in Universe 2347th / 6846

BRIEF-Diasorin sees 53% of revenues in U.S. thanks to Luminex deal

Mon 12th April, 2021 2:04pm
April 12 (Reuters) - Diasorin  DIAS.MI  CEO Carlo Rosa tells
analysts in a conference call:
    * WITH LUMINEX COMBINATION AROUND 53% OF REVENUES WILL COME
FROM
UNITED STATES


Further company coverage:  DIAS.MI 

 (Reporting by Milan Newsroom)
 ((cristina.carlevaro@thomsonreuters.com; +39 02 66129585;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.